characteristics.text: SAMN00139318
characteristics.characteristic: External Id
characteristics.text: Pacific Biosciences
characteristics.characteristic: INSDC center name
characteristics.text: 2010-12-10T15:31:17.570Z
characteristics.characteristic: INSDC first public
characteristics.text: 2013-06-12T09:01:01.833Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS140101
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS140101
characteristics.characteristic: SRA accession
characteristics.text: Samples of spontaneously passed stool from two patients who had received a clinical diagnosis of cholera were cultured. Both patients received standard medical treatment for cholera, as appropriate to their clinical conditions. Bacterial isolates (H1 and H2) were shipped to the United States, with the use of an import license for this purpose (2010-10-108) that was provided through the Centers for Disease Control and Prevention (CDC). Isolates were identified as V. cholerae and were determined to be susceptible to tetracycline and erythromycin but resistant to trimethoprim-sulfamethoxazole and nalidixic acid.
characteristics.characteristic: description
characteristics.text: Vibrio cholerae O1 biovar El Tor
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_686
characteristics.characteristic: organism
characteristics.text: 01
characteristics.characteristic: serotype
characteristics.text: H2 (Haiti, 2010)
characteristics.characteristic: title